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Objective: The objective of this study was to review the early clinical profiles and 
outcomes of very-low-birth-weight (VLBW) neonates with late-onset sepsis caused 
by Enterobacter cloacae.
Methods: We reviewed the medical records of VLBW neonates whose blood and/or 
cerebral spinal fluid yielded E. cloacae after 3 days of hospitalization in our neonatal 
intensive care unit.
Results: From January 1997 to December 2006, a total of 29 episodes of E. cloacae 
infection occurred in 28 VLBW neonates. The onset of E. cloacae infection ranged 
from 4 to 70 days (27.4 ± 9.6) days after birth. The most common symptoms and 
signs of sepsis were desaturation (58.6%), tachycardia (58.6%), apnea (55.2%), 
unstable body temperature (48.3%), and decreased activity (44.8%). The infected 
neonates had an average of four kinds of symptoms in each sepsis episode. The most 
common laboratory findings in VLBW neonates with E. cloacae sepsis were throm-
bocytopenia (65.5%), C-reactive protein  1 mg/dL (55.2%), band-form neutrophils 
 5% (41.4%), and leucopoenia (20.7%). Empirical intravenous antibiotic therapy 
comprising piperacillin (or piperacillin and tazobactam) and gentamicin (or amikacin) 
was successful in the early treatment of 24 episodes of E. cloacae sepsis in 25 
patients. Three neonates (10.7%) died due to E. cloacae sepsis. Four neonates (14.3%) 
developed E. cloacae meningitis, and two of them developed brain abscesses.
Conclusions: E. cloacae infection in VLBW neonates usually presents with non-
specific symptoms and signs. Early recognition of sepsis and empirical combination 
of piperacillin (or piperacillin and tazobactam) and gentamicin (or amikacin) may 
be useful for treatment of sepsis caused by this highly virulent pathogen.
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very low birth weight 
1. Introduction
Enterobacter cloacae are gram-negative bacilli caus-
ing nosocomial infection in the neonatal intensive 
care unit (NICU). This bacteria can cause fulminant 
late-onset sepsis, a condition associated with a 
relatively high mortality and morbidity.1−3 Previ-
ous studies have usually included both term and 
premature neonates.3,4 No reports have detailed 
the clinical manifestations, treatment courses and 
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outcomes specific to these infections in very-low-
birth-weight (VLBW) neonates.
2. Patients and Methods
We retrospectively reviewed the medical records 
of VLBW (birth body weight  1500 g) neonates 
admitted to the NICU of our hospital from January 
1997 to December 2006. Our NICU is a 24-bed ter-
tiary referral center for neonates in central Taiwan. 
Late-onset sepsis was diagnosed if blood and/or 
cerebral spinal fluid (CSF) cultures sampled after the 
neonates were admitted in the NICU over 72 hours 
and yielded E. cloacae in addition to the presence 
of clinical symptoms and signs of sepsis. The symp-
toms and signs of sepsis included fever (> 37.8ºC), 
low-grade fever ( 37.8ºC and  37.2ºC), hypother-
mia (< 36ºC), apnea (no breathing movement for 
20 seconds, or for a shorter duration in the presence 
of cyanosis), bradycardia (heart rate < 80 bpm), de-
saturation (oxygen saturation SpO2 < 85%), tachy-
cardia (heart rate > 150 beats per minute), tachypnea 
(respiratory rate over 50 breaths per minute), sig-
nificant residual milk (over 30% of the preceding 
feeding amount), hypoglycemia (whole-blood glucose 
level lower than 40 mg/dL), hyperglycemia (whole-
blood glucose level higher than 125 mg/dL) and 
thrombocytopenia (platelet count  100,000/mm3). 
Blood culture, complete blood cell count, and C-
reactive protein (CRP) were checked on the day 
that infection was suspected and followed up the 
following day. All E. cloacae isolates were subjected 
to antimicrobial susceptibility testing by a standard 
agar diffusion method (Sensi-Disc, Becton, Dickinson 
and Company, ML, USA). Lumbar puncture was per-
formed in patients suspected of having meningitis. 
Blood and CSF cultures were collected and cultured 
according to standard microbiologic techniques.
3. Results
During the 10-year study period, E. cloacae ac-
counted for 21.7% of all neonatal sepsis and 49.3% 
of all infections caused by gram-negative aerobic 
bacteria in our NICU. A total of 28 neonates, 14 boys 
and 14 girls (aged 4 days to 70 days) who developed 
29 episodes of late-onset E. cloacae sepsis (onset 
≥ 72 hours after admission to the NICU), were in-
cluded in this retrospective study. The 28 neonates 
were inborn infants or outborn infants referred from 
other obstetric clinics immediately after their birth. 
All of them were hospitalized in the NICU for at least 
5 days. There were three outbreaks during the study 
period in our NICU; each outbreak included two to 
three blood culture-confirmed patients with a total 
of eight infected neonates. These outbreaks were 
controlled after cohort nursing and hygienic manage-
ment without changing antibiotic policy. The other 
21 infants were sporadic cases in this study period.
Thirteen (46.4%) neonates were born before 28 
weeks’ gestation and 12 (42.9%) were born at 28 to 
32 weeks’ gestation. Sixteen (57.1%) neonates were 
born with body weights of less than 1000 g. The av-
erage days of onset of E. cloacae infection after 
birth was 27.4 ± 9.6 days (range: 4 to 70 days).
Twenty-three neonates (79.3%) were under per-
cutaneous central venous catheterization (PCVC) 
and enteral feeding when infection occurred. Twelve 
of them were totally or partially fed with breast 
milk. Five (17.2%) neonates were on mechanical 
ventilators, and four (13.8%) were on continuous 
positive airway pressure ventilation.
The symptoms and signs of sepsis included 
desaturation, tachycardia, apnea, unstable temper-
ature, abdominal distention, decreased activity, 
tachypnea, bradycardia, abdominal distension, and 
significant residual milk (Table 1). The infected 
neonates had an average of 3.9 ± 1.5 kinds (range, 
1 to 7 kinds) of symptoms in each sepsis episode. 
The laboratory tests showed thrombocytopenia in 
nine (65.5%) neonates, CRP  1 mg/dL in 16 (55.2%) 
(normal  0.5 mg/dL), band-form neutrophils  5% 
in 12 (41.4%) neonates and white cell count  5000/
dL in six (20.7%) neonates.
Of the E. cloacae isolate strains, 21.4% were sen-
sitive to piperacillin (or piperacillin and tazobactam), 
Table 1  Symptoms and signs of E. cloacae sepsis in 
neonates
Signs and symptoms n (%)
Desaturation SpO2 < 85% 17 (58.6)
Tachycardia > 150 beats per  17 (58.6)
minute (bpm)
Apnea 16 (55.2)
Unstable temperature* 14 (48.3)
 Low-grade fever  37.8ºC and  37.2ºC 6 (20.7)
 Fever > 37.8ºC 7 (24.1)
 Hypothermia < 36ºC 1 (3.4)
Decreased activity 13 (44.8)
Tachypnea > 50 bpm 13 (44.8)
Bradycardia < 80 bpm 9 (31.0)
Abdominal distention 8 (28.6)
Residual milk > 30% preceding amount 6 (21.4)
Hyperglycemia > 125 mg/dL 4 (14.3)
Hypoglycemia < 40 mg/dL 1 (3.6)
Hypotension < 40 mmHg systolic 1 (3.6)
*Low grade fever, fever or hypothermia.
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27.9% were sensitive to third-generation cepha-
losporins, 31.0% were sensitive to aminoglycosides, 
and 100% were sensitive to imipenem and cipro-
floxacine. Extended-spectrum β-lactamase (ESBL) 
tests were not performed regularly at that period.
Empirical intravenous antibiotics comprising 
piperacillin (or piperacillin and tazobactam) and 
gentamicin (or amikacin) were prescribed when 
symptoms and signs of sepsis were suspected. 
Vancomycin or teicoplanin were empirically added 
to the regimens in 11 neonates. These regimens 
were successful in stabilizing vital signs and con-
trolling infection in 24 of the 25 neonates who sur-
vived. Antibiotics were shifted to imipenem in 
12 patients according to the susceptibility testing 
results. Antibiotics were given to neonates with 
sepsis for a period of 2 weeks and to neonates with 
meningitis for a period of at least 4 weeks.
The mortality rate of these VLBW infants was 
21.4% (n = 6). Three neonates (10.7%) died due to 
E. cloacae sepsis. The E. cloacae cultured from 
those three neonates were multiresistant strains 
and sensitive to ciprofloxacin and imipenem only. 
They were ventilated and had body weights less 
than 800 g; one died 1 day after the onset of infec-
tion and two died 6 days later after 3 and 4 days of 
imipenem and supportive treatment. The other 
three patients died due to fungal sepsis, chylotho-
rax, and Staphylococcus aureus respectively, after 
having recovered from E. cloacae sepsis. Only 10 
of the 28 neonates received lumbar puncture dur-
ing sepsis; the others were considered too sick to 
tolerate the procedure. Four of the ten had men-
ingitis, with sequelae of seizure and developmen-
tal delay. Two of these four neonates had brain 
abscesses but there was no significant risk factor 
associated with the brain abscesses noticed. Brain 
ultrasound, computed tomography (CT), and/or 
brain magnetic resonance imaging (MRI) were 
performed on the 22 surviving neonates before 
discharge from the hospital. The final outcomes 
are shown in Table 2.
4. Discussion
The risk factors of E. cloacae infection in neonates 
include being small for gestational age,5 having 
low birth weight,5,6 ongoing parenteral nutrition,7 
understaffing,6 over-crowding,6 poor hygienic prac-
tices,6 contaminated thermometers,8 presence of 
E. cloacae in the stool carriage5 and exposure to 
personnel with contaminated hands.5,6
The incidence of E. cloacae nosocomial infection 
in VLBW neonates ranges from 2.5% to 19.2%.3,9−11 
In our NICU, E. cloacae was the leading microorgan-
ism in neonatal gram-negative bacilli sepsis as in 
some other reports.10,12 The higher rate (21.7%) of 
E. cloacae sepsis may be partly related to the three 
outbreaks in the study period and partly related to 
the specific environmental factors of our NICU.
The relative late onset of E. cloacae infection 
(median, 27.4 days) after birth in our series may be 
associated with the fact that 57.1% of our neonates 
had birth weights of less than 1000 g requiring them 
to stay longer in the NICU. E. cloacae infection may 
occur later in stable and well-fed VLBW neonates 
as it is a common organism in the intestinal tract 
of neonates in the NICU.13
Enterobacter species can colonize the gut of 
neonates, the risk increases with the duration of 
hospitalization; 60% after 15 days and 91% after 30 
days. It may arise endogenously and increase the 
infection risk among premature infants.4,5,13−15 Pre-
vention strategies should focus more on the con-
trol of endogenous neonatal flora or environmental 
sources.16
Breast feeding and reduced exposure to antibiot-
ics can increase microbial diversity in the feces of 
extremely low-birth-weight infants.17 Breast-feeding 
therefore is highly recommended to reduce the 
amount of pathogenic bacteria in the intestinal tract 
of VLBW neonates. But it was reported that a lack of 
breast feeding was not associated with isolation of 
gram-negative bacilli from stools.15 We did not no-
tice significant protection from E. cloacae infection 
due to breast milk in the 12 neonates who were 
totally or partially fed with breast milk in our study.
Because of the high incidence of mortality and 
morbidity among VLBW neonates, early identifica-
tion of sepsis in neonates is important. But in our 
study, the common symptoms and signs of E. cloacae 
infection in VLBW neonates were nonspecific, in-
cluding desaturation, tachycardia, apnea, unstable 
temperature, decreased activity, and tachypnea. 
It is difficult to identify early the VLBW neonate 
infected with E. cloacae by these nonspecific signs. 
Table 2  Outcomes of 28 neonates with E. cloacae 
sepsis
Morbidity and mortality n (%)
Total mortality 6 (21.4)
Mortality due to E. cloacae sepsis 3 (10.7)
Seizure 9 (32.1)
Retinopathy of prematurity  8 (28.6)
Patent ductus arteriosus  6 (21.4)
Cholestasis 5 (17.9)
Meningitis and/or brain abscess 4 (17.4)
Necrotizing enterocolitis  4 (14.3)
Chronic lung disease 4 (14.3)
Periventricular leucomalacia 3 (10.7)
Intraventricular hemorrhage  grade III 2 (7.1)
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Our observation is consistent with the reports that 
nonspecific clinical and hematological signs of late-
onset sepsis are similar across enteric gram-negative 
bacilli infections.3,18
These infected VLBW neonates had an average 
of four kinds of symptoms occurring simultaneously 
early on the first symptomatic day. Further labora-
tory tests for evidence of thrombocytopenia, leu-
copoenia, band-form neutrophils  5% and elevated 
CRP for identification of the severe infection may 
be needed in these infants.
In our series, PCVC was the most common ther-
apeutic intervention that neonates were undergo-
ing when infection occurred. PCVC was reserved 
for parenteral nutrition and was usually related to 
the late-onset infection in NICU neonates.7,11,18−21 
It was reported that minimizing the use of central 
venous catheter and reducing the number of cath-
eter days would decrease the risk of infection.11 
But there were studies which reported that the 
protective effect of appropriate catheter care may 
be less relevant for the prevention of blood stream 
infections associated with gram-negative bacteria 
in VLBW than for the prevention of infection caused 
by gram-positive cocci.16 This observation is sup-
ported by the reports that state that gram-negative-
bacilli species isolated from the neonatal blood 
stream and nurses’ hands vary significantly.16,22
Drug resistance is a major therapeutic problem 
in treating E. cloacae sepsis. Jean et al reported 
that 97% of the E. cloacae strains isolated in their 
study were resistant to multiple antibiotics.23 Jain 
et al reported that 73.4% of E. cloacae produced 
ESBL and 74 to 81% of these ESBL producers were 
resistant to cefotaxime.24 Considering the aggres-
sive nature of sepsis caused by the pathogen, em-
piric treatment against bacilli producing ESBL is 
important in VLBW infants.25 Indiscriminate use of 
third-generation cephalosporins may be responsi-
ble for the selection of ESBL-producing strains.24 
De Man et al reported the relative risk for coloniza-
tion with strains resistant to the empirical therapy 
was 18 times higher for the amoxicillin-cefotaxime 
regimen compared with the penicillin-tobramycin 
regimen.26 There was a high incidence (70%) of 
E. cloacae resistant to the empirical antibiotics regi-
mens in our series. But due to the restriction of 
laboratory facilities, ESBL testing was unable to be 
performed in the early stage of the study period 
and we could not know the incidence of the ESBL 
rate among these infections. The mortality rate of 
our series was 10.7% lower than that reported in the 
literature (6.2%−40%).1,2,11,21,25,27 We suggest that 
empirical treatment of piperacillin (or piperacillin 
and tazobactam) with gentamicin (or amikacin) 
might have some effect for empirical treatment of 
neonatal sepsis caused by multi-resistant E. cloacae. 
Considering the three mortality cases were infected 
by strains that were resistant to piperacillin and 
amikacin. The antibiotic regimen should be adjusted 
immediately according to the susceptibility testing 
results.
CSF examinations and follow-up sonography, CT 
or MRI of the brain are recommend in these in-
fected infants.28 The incidence of meningitis in our 
series may be underestimated because less than 
half of our patients underwent lumbar puncture 
examination. All four infants with meningitis and/
or brain abscesses survived with mild neurological 
sequelae. The result is better than other reports on 
VLBW infants Enterobacter spp. meningitis, in which 
such neonates had high incidence of morbidity and 
mortality.5,8 Unlike neonatal Enterobacter sakazaki 
sepsis, which has high incidence of brain abscess, 
brain abscesses were rarely reported in previous 
E. cloacae neonatal sepsis studies.
Our study includes a comprehensive review of 
the early symptoms and signs, treatment regimens 
and outcomes of E. cloacae sepsis among VLBW 
neonates. The limitation of our study is its retro-
spective nature and relative small sample size.
In summary, the common symptoms and signs of 
E. cloacae infection in VLBW neonates were non-
specific but multiple kinds occur simultaneously. 
Early recognition of these symptoms and signs of 
sepsis followed by laboratory test confirmation with 
empirical treatment of piperacillin (or piperacillin 
and tazobactam) and gentamicin (or amikacin), then 
adjusting the antibiotics by susceptibility test, may 
be helpful in treatment of late-onset sepsis caused 
by E. cloacae in VLBW neonates.
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